110 related articles for article (PubMed ID: 9586629)
1. A tale of two T cells.
Janeway CA
Immunity; 1998 Apr; 8(4):391-4. PubMed ID: 9586629
[No Abstract] [Full Text] [Related]
2. In vivo selection of T-cell receptor junctional region sequences by HLA-A2 human T-cell lymphotropic virus type 1 Tax11-19 peptide complexes.
Saito M; Taylor GP; Saito A; Furukawa Y; Usuku K; Weber JN; Osame M; Bangham CR
J Virol; 2001 Jan; 75(2):1065-71. PubMed ID: 11134322
[TBL] [Abstract][Full Text] [Related]
3. Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids.
Ding YH; Smith KJ; Garboczi DN; Utz U; Biddison WE; Wiley DC
Immunity; 1998 Apr; 8(4):403-11. PubMed ID: 9586631
[TBL] [Abstract][Full Text] [Related]
4. Structural, biochemical, and biophysical studies of HLA-A2/altered peptide ligands binding to viral-peptide-specific human T-cell receptors.
Baker BM; Ding YH; Garboczi DN; Biddison WE; Wiley DC
Cold Spring Harb Symp Quant Biol; 1999; 64():235-41. PubMed ID: 11232291
[No Abstract] [Full Text] [Related]
5. T-cell repertoire and HIV infection: facts and perspectives.
Cossarizza A
AIDS; 1997 Jul; 11(9):1075-88. PubMed ID: 9233453
[No Abstract] [Full Text] [Related]
6. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature. 1996. 384: 134-141.
Garboczi DN; Ghosh P; Utz U; Fan QR; Biddison WE; Wiley DC
J Immunol; 2010 Dec; 185(11):6394-401. PubMed ID: 21084668
[No Abstract] [Full Text] [Related]
7. Identification of a crucial energetic footprint on the alpha1 helix of human histocompatibility leukocyte antigen (HLA)-A2 that provides functional interactions for recognition by tax peptide/HLA-A2-specific T cell receptors.
Baker BM; Turner RV; Gagnon SJ; Wiley DC; Biddison WE
J Exp Med; 2001 Mar; 193(5):551-62. PubMed ID: 11238586
[TBL] [Abstract][Full Text] [Related]
8. HBsAg/HLA-A2 transgenic mice: a model for T cell tolerance to hepatitis B surface antigen in chronic hepatitis B virus infection.
Loirat D; Mancini-Bourgine M; Abastado JP; Michel ML
Int Immunol; 2003 Oct; 15(10):1125-36. PubMed ID: 13679383
[TBL] [Abstract][Full Text] [Related]
9. Avidity characterization of genetically engineered T-cells with novel and established approaches.
Hillerdal V; Boura VF; Björkelund H; Andersson K; Essand M
BMC Immunol; 2016 Jul; 17(1):23. PubMed ID: 27411667
[TBL] [Abstract][Full Text] [Related]
10. A novel Epstein-Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy.
Cho HI; Kim UH; Shin AR; Won JN; Lee HJ; Sohn HJ; Kim TG
Br J Cancer; 2018 Feb; 118(4):534-545. PubMed ID: 29360818
[TBL] [Abstract][Full Text] [Related]
11. Not just another Fab: the crystal structure of a TcR-MHC-peptide complex.
Jardetzky T
Structure; 1997 Feb; 5(2):159-63. PubMed ID: 9032079
[TBL] [Abstract][Full Text] [Related]
12. The problem of plain vanilla peptides.
Davis MM
Nat Immunol; 2003 Jul; 4(7):649-50. PubMed ID: 12830143
[No Abstract] [Full Text] [Related]
13. Conserved CDR3 regions in T-cell receptor (TCR) CD8(+) T cells that recognize the Tax11-19/HLA-A*0201 complex in a subject infected with human T-cell leukemia virus type 1: relationship of T-cell fine specificity and major histocompatibility complex/peptide/TCR crystal structure.
Bourcier KD; Lim DG; Ding YH; Smith KJ; Wucherpfennig K; Hafler DA
J Virol; 2001 Oct; 75(20):9836-43. PubMed ID: 11559817
[TBL] [Abstract][Full Text] [Related]
14. Redirection of T cells by delivering a transgenic mouse-derived MDM2 tumor antigen-specific TCR and its humanized derivative is governed by the CD8 coreceptor and affects natural human TCR expression.
Voss RH; Kuball J; Engel R; Guillaume P; Romero P; Huber C; Theobald M
Immunol Res; 2006; 34(1):67-87. PubMed ID: 16720899
[TBL] [Abstract][Full Text] [Related]
15. Cooperation of human tumor-reactive CD4+ and CD8+ T cells after redirection of their specificity by a high-affinity p53A2.1-specific TCR.
Kuball J; Schmitz FW; Voss RH; Ferreira EA; Engel R; Guillaume P; Strand S; Romero P; Huber C; Sherman LA; Theobald M
Immunity; 2005 Jan; 22(1):117-29. PubMed ID: 15664164
[TBL] [Abstract][Full Text] [Related]
16. CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement.
Stone JD; Stern LJ
J Immunol; 2006 Feb; 176(3):1498-505. PubMed ID: 16424178
[TBL] [Abstract][Full Text] [Related]
17. Fully functional HLA B27-restricted CD4+ as well as CD8+ T cell responses in TCR transgenic mice.
Roddis M; Carter RW; Sun MY; Weissensteiner T; McMichael AJ; Bowness P; Bodmer HC
J Immunol; 2004 Jan; 172(1):155-61. PubMed ID: 14688321
[TBL] [Abstract][Full Text] [Related]
18. Clonal diversity of the T-cell population responding to a dominant HLA-A2 epitope of HER-2/neu after active immunization in an ovarian cancer patient.
Knutson KL; Disis ML
Hum Immunol; 2002 Jul; 63(7):547-57. PubMed ID: 12072190
[TBL] [Abstract][Full Text] [Related]
19. T cell receptor-alpha beta lacking the beta-chain V domain can be expressed at the cell surface but prohibits T cell maturation.
Ossendorp F; Jacobs H; van der Horst G; de Vries E; Berns A; Borst J
J Immunol; 1992 Jun; 148(12):3714-22. PubMed ID: 1351085
[TBL] [Abstract][Full Text] [Related]
20. The role of B7 costimulation in CD4/CD8 T cell homeostasis.
Yu X; Fournier S; Allison JP; Sharpe AH; Hodes RJ
J Immunol; 2000 Apr; 164(7):3543-53. PubMed ID: 10725709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
